48,830
edits
Difference between revisions of "CDX2"
Jump to navigation
Jump to search
no edit summary
| Line 26: | Line 26: | ||
*Intestinal adenocarcinomas. | *Intestinal adenocarcinomas. | ||
**[[Colorectal adenocarcinoma]] ~ 90% of cases.<ref name=pmid13679455/> | **[[Colorectal adenocarcinoma]] ~ 90% of cases.<ref name=pmid13679455/> | ||
*[[Neuroendocrine tumours]].<ref name=pmid15640551>{{cite journal |authors=Erickson LA, Papouchado B, Dimashkieh H, Zhang S, Nakamura N, Lloyd RV |title=Cdx2 as a marker for neuroendocrine tumors of unknown primary sites |journal=Endocr Pathol |volume=15 |issue=3 |pages=247–52 |date=2004 |pmid=15640551 |doi=10.1385/ep:15:3:247 |url=}}</ref> | |||
====Sometimes positive==== | ====Sometimes positive==== | ||